The 3.2-Å-resolution X-ray structure of enterovirus 71 with WIN 51711 provides a structural basis for developing capsid-binding antiviral drugs.
Answers are grounded in this paper and cite their sources.
Supports capsid-binding antiviral development for enterovirus 71; leaves open clinical efficacy and safety in humans.
Human enterovirus 71 is a picornavirus causing hand, foot, and mouth disease that may progress to fatal encephalitis in infants and small children. As of now, no cure is available for enterovirus 71 infections. Small molecule inhibitors binding into a hydrophobic pocket within capsid viral protein 1 were previously shown to effectively limit infectivity of many picornaviruses. Here we report a 3.2-Å-resolution X-ray structure of the enterovirus 71 virion complexed with the capsid-binding inhibitor WIN 51711. The inhibitor replaced the natural pocket factor within the viral protein 1 pocket without inducing any detectable rearrangements in the structure of the capsid. Furthermore, we show that the compound stabilizes enterovirus 71 virions and limits its infectivity, probably through restricting dynamics of the capsid necessary for genome release. Thus, our results provide a structural basis for development of antienterovirus 71 capsid-binding drugs.
No takes yet. Share an insight, caveat, or question.
Plevka et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: